Uterine Artery Embolization for the Treatment of Adenomyosis: A Systematic Review and Meta-Analysis

Annefleur M. de Bruijn*, Marieke Smink, Paul N.M. Lohle, Judith A.F. Huirne, Jos W.R. Twisk, Caroline Wong, Linda Schoonmade, Wouter J.K. Hehenkamp

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

The effect of uterine artery embolization (UAE) on symptomatic adenomyosis was evaluated in a systematic review and meta-analysis. Four groups were evaluated: short-term (< 12 months) pure adenomyosis, short-term adenomyosis with fibroids (combined adenomyosis), long-term (> 12 months) pure adenomyosis, and long-term combined adenomyosis. Improvement of symptoms occurred in 83.1% (872/1,049) of patients. Reported symptom reduction was 4.8% greater in the short-term combined group (P = .169) and 11.4% greater in the long-term combined group (P = .003). Uterine volume was reduced in all patients at 3 months. The effects of UAE on symptom improvement and uterine volume reduction in patients with adenomyosis are encouraging.

Original languageEnglish
JournalJournal of Vascular and Interventional Radiology
Volume28
Issue number12
DOIs
Publication statusPublished - Dec 2017

Cite this